Lumos Pharma, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -4.68 | -100% |
| P/S |
|
12.07 | 33.76 | -64.24% |
|
|
| P/BV |
|
0.9068 | 4.82 | -81.19% |
|
|
| P/FCF |
|
0 | 60.98 | -100% |
|
|
| Ev/Ebitda |
|
0.102 | -22.12 | -100.46% |
|
|
| Ev/S |
|
-1.82 | 22.56 | -108.06% |
|
|
| Ev/FCF |
|
0.12 | 68.75 | -99.83% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-1783.03 | 4.83 | -37012.99% | -7551.09 | -76.39% |
| ROE |
|
-124.64 | 9.61 | -1397.54% |
|
|
| ROA |
|
-83.75 | 0.3359 | -25032.37% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-1659.39 | -25.17 | 6492.7% |
|
|
| ROCE |
|
-134.09 | 15.33 | -974.64% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1801 | -3.67 | -95.09% | -0.0795 | 126.38% |
| Nеt Debt/Ebitda |
|
0.7791 | -3.44 | -122.66% |
|
|
| Debt/Ratio |
|
0.162 | 0.1972 | -17.81% |
|
|
| Debt/Equity |
|
0 | 1.65 | -100% |
|
|
| Debt/Net Income |
|
-0.1935 | 10.31 | -101.88% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5496 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.1053 | -100% |
|
|
| DSI |
|
0 | 0.2174 | -100% |
|
|
| Average dividend growth |
|
0 | 0.0654 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
2.36 | 43.56 | -94.59% |
|
|
| Difference from average difference in sector |
|
-0.5496 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
10/10
|
119.12 | -56.89 | -309.39% |
| Growth impulse Ebitda 5 years |
|
-14.76 | -64.81 | -77.23% |
| Growth impulse Net Income 5 years |
|
-20.85 | -58.33 | -64.26% |
| Growth impulse FCF 5 years |
|
2.96 | -47 | -106.3% |
| Growth impulse EPS 5 years |
|
-87.34 | -32.41 | 169.48% |
IP Score
3.41/10
